IHJ Cardiovascular Case Reports (Apr 2023)

Use of Impella 5.5 in patients with cardiogenic shock as a bridge to decision, recovery, or destination therapy

  • Anju Bhardwaj,
  • Ismael Salas De Armas,
  • Dina Al Rameni,
  • Manish Patel,
  • Mehmet H. Akay,
  • Biswajit Kar,
  • Igor D. Gregoric

Journal volume & issue
Vol. 7, no. 2
pp. 61 – 64

Abstract

Read online

The overall morbidity and mortality rates of cardiogenic shock are high. The Impella 5.5 is a temporary mechanical circulatory support device that treats cardiogenic shock by supporting a failing ventricle. It is used as a bridge to advanced therapy, decision, or recovery. We report our initial experience with this device.

Keywords